Upal Basu Roy
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Virology top 5%
- HIV Research and Treatment
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
- Oncology 11
- Drug Transport and Resistance Mechanisms 4
- COVID-19 and healthcare impacts 3
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Debasis Mondal (8 shared papers)Howard Eliot Gendelman (9 shared papers)JoEllyn McMillan (7 shared papers)Madhavan Nair (7 shared papers)Shantanu S. Balkundi (6 shared papers)Yogesh Shreepad Shouche (3 shared papers)Siddhartha P. Sarma (1 shared paper)T. Prem Anand (1 shared paper)
- Journals
- Journal of Thoracic Oncology (7 papers)International Journal of Nanomedicine (3 papers)Scientific Reports (3 papers)Future Oncology (3 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- United StatesJapanIndia
In The Last Decade
Upal Basu Roy
60 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 79
- Biomaterials 283
- Virology 115
- Biotechnology 77
- Pharmaceutical Science 45
- Oncology 116
Countries citing papers authored by Upal Basu Roy
This map shows the geographic impact of Upal Basu Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Upal Basu Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Upal Basu Roy more than expected).
Fields of papers citing papers by Upal Basu Roy
This network shows the impact of papers produced by Upal Basu Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Upal Basu Roy. The network helps show where Upal Basu Roy may publish in the future.
Co-authors
The 25 scholars most cited alongside Upal Basu Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 165 | |
| 2 | 2012 | 111 | |
| 3 | 2015 | 106 | |
| 4 | 2016 | 106 | |
| 5 | 2010 | 97 | |
| 6 | 2018 | 86 | |
| 7 | 2009 | 81 | |
| 8 | 2013 | 67 | |
| 9 | 2019 | 67 | |
| 10 | 2008 | 66 | |
| 11 | 2021 | 58 | |
| 12 | 2012 | 57 | |
| 13 | 2015 | 48 | |
| 14 | 2012 | 45 | |
| 15 | 2015 | 45 | |
| 16 | 2011 | 43 | |
| 17 | 2022 | 36 | |
| 18 | 2011 | 34 | |
| 19 | 2013 | 28 | |
| 20 | 2023 | 28 |
About Upal Basu Roy
Upal Basu Roy is a scholar working on Biomaterials, Oncology, Virology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 62 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), HIV Research and Treatment (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Ethics in Clinical Research (3 papers), COVID-19 and healthcare impacts (3 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Biomaterials (283 citations), Virology (115 citations), Biotechnology (77 citations), Pharmaceutical Science (45 citations) and Oncology (116 citations). Upal Basu Roy has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Debasis Mondal, Howard Eliot Gendelman, JoEllyn McMillan, Madhavan Nair, Shantanu S. Balkundi, Yogesh Shreepad Shouche, Siddhartha P. Sarma, T. Prem Anand, Jay Siddharth and Yazen Alnouti. Their work appears in journals such as Journal of Thoracic Oncology, International Journal of Nanomedicine, Scientific Reports, Future Oncology and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.